Diana D Cirstea
7PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.Viktoria Blumenberg, Filippo Birocchi, Angela Shih
|Jul 21, 2025
Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.Rahul Banerjee, Meera Mohan, Kai Rejeski
|Jun 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.Jessica S Little, Angelica Medina Pena, E Bridget Kim
|Apr 09, 2025
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma.Joshua N Gustine, Andrew R Branagan, Diana D Cirstea
|Mar 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment.Viktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham
|Mar 14, 2025
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury.E Bridget Kim, Jack E Malespini, Matthew Lei
Pageof 2
Frequent Collaborators
5 joint publications
Andrew J Yee
4 joint publications
Andrew R Branagan
3 joint publications
Benjamin R Puliafito
3 joint publications
Marcela V Maus
2 joint publications
Viktoria Blumenberg
2 joint publications
Mark B Leick
1 joint publications
Nathanael R Fillmore
1 joint publications
Clark DuMontier
1 joint publications
Gregory A Abel
1 joint publications
Dae H Kim
